International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Formulation and in vitro evaluation of Diltiazem controlled release tablets

Article Information

Volume / Issue5 / 1 (January-December 2024)
Pages38-41
AccessOpen Access

Publication Timeline

  • Received02 January 2024
  • Accepted05 February 2024

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

The aim of the present work is to Formulate and Evaluate controlled release of Diltiazem matrix tablets used for treat high blood pressure and control angina.   Development of CR Diltiazem is proposed considering the adverse event profile and high fluctuation index of Diltiazem observed with IR dosage forms. In the present work, attempts were made to formulate and evaluate controlled release of matrix tablets of Diltiazem.  Diltiazem was subjected to preformulation studies, based on the results obtained Diltiazem controlled release tablets were successfully formulated. Formulations prepared by wet granulation using HPMC and carbopol 934 as control release polymers and 5% W/W of povidone in isopropyl alcohol as binder solution have showed desired in vitro release. Set of trials were formulated for which Diltiazem evaluated parameters (bulk density, tapped density, compressibility index, hausner’s ratio, weight, thickness, hardness) were found to lie within the specifications. Dissolution study was performed in USP type II apparatus at 100 RPM in pH 6.8 phosphate phosphate buffer. 

References

  1. Kumar P, Kijjal R. Novel oral sustained release drug technology: a concise review. International Journal of Research and Development in Pharmaceutical Sciences. 2013;2:262-9. [Google Scholar][Crossref]
  2. Alexander A, Singh A. Herbal drugs used for the treatment of asthma: an overview. International Journal of Current Biomedical and Pharmaceutical Research. International Journal of Medical and All Body Health Research www.allmedicaljournal.com 2011;1(2):67-79. [Google Scholar][Crossref]
  3. Kumar RM. Nano and microparticles as controlled drug delivery devices. Journal of Pharmacy and Pharmaceutical Sciences. 2000;3:234-58. [Google Scholar][Crossref]
  4. Ummadi S, Shravani B, Raghavendra Rao NG, Srikanth Reddy M, Sanjeev Nayak B. Overview on controlled release dosage form. International Journal of Pharma Sciences. 2013;3(4):258-69. [Google Scholar][Crossref]
  5. Brahmankar DM, Jaiswal SB. Biopharmaceutics and Pharmacokinetics: A Treatise. 1st ed. New Delhi: Vallabh Prakashan; 1995. p. 336-7. [Google Scholar][Crossref]
  6. Abdel-Rahman SI, Mahrous GM, El -Badry M. Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets. Saudi Pharmaceutical Journal. 2009;17:283–8. [Google Scholar][Crossref]
  7. Sinha Roy D, Rohera BD. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. European Journal of Pharmaceutical Sciences. 2002;16:193-9. [Google Scholar][Crossref]
  8. Kashyap P, Tripathi DK. Microwave assisted eco-friendly synthesis, characterization and in-vitro release behavior of carboxymethyl xanthan gum. Current Microwave Chemistry ; c2015. doi:10.2174/2213335602666151022203648 [Google Scholar][Crossref]
  9. Giri TK, Choudhary C, Alexander A, Tripathy M, Tripathi DK. Sustained release of diltiazem hydrochloride from cross-linked biodegradable IPN hydrogel beads of pectin and modified xanthan gum. Indian Journal of Pharmaceutical Sciences; c2013. [Google Scholar][Crossref]
  10. Giri TK, Thakur D, Alexander A, Tripathi M, Tripathi DK. Biodegradable IPN hydrogel beads of pectin and grated alginate for controlled delivery of diclofenac sodium. Journal of Materials Science: Materials in Medicine; c2016. [Google Scholar][Crossref]
  11. Giri TK, Verma S, Alexander A, Tripathy M, Tripathi DK. Crosslinked biodegradable alginate hydrogel floating beads for stomach site-specific controlled drug delivery of metronidazole. Farmacia; c2013. Copyright and License © 2026 The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. [Google Scholar][Crossref]

How to Cite

Taquuidin, Prasad, N. B., Vasudha, S., Sameer, A., & Divya, M. (2024). Formulation and in vitro evaluation of Diltiazem controlled release tablets. International Journal of Medical and All Body Health Research, 5(1), 38-41.

Taquuidin, et al. "Formulation and in vitro evaluation of Diltiazem controlled release tablets." International Journal of Medical and All Body Health Research, vol. 5, no. 1, 2024, pp. 38-41.

Taquuidin, Prasad, N. B., Vasudha, S., Sameer, A. and Divya, M. (2024) 'Formulation and in vitro evaluation of Diltiazem controlled release tablets', International Journal of Medical and All Body Health Research, 5(1), pp. 38-41.

Taquuidin, Prasad NB, Vasudha S, Sameer A, Divya M. Formulation and in vitro evaluation of Diltiazem controlled release tablets. International Journal of Medical and All Body Health Research. 2024;5(1):38-41.

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex ResearchGate BASE

A newly published article may take a few days to appear on these services.